The largest database of trusted experimental protocols

Pt 3273

Manufactured by Lonza

The PT-3273 is a lab equipment product. It is a multi-purpose instrument designed for use in various laboratory applications. The core function of the PT-3273 is to perform precise measurements and analysis. Further details on the intended use of this product are not available.

Automatically generated - may contain errors

3 protocols using pt 3273

1

TGFβ1 and Scleroderma Serum Effects on ADSC

Check if the same lab product or an alternative is used in the 5 most similar protocols
In selected experiments, ADSC were grown to 70% confluence, washed three times with serum-free medium and cultured in ADSC basal medium (catalog no. PT-3273, Lonza) supplemented with 2% fetal bovine serum for 24 h. Medium was removed and cells were then incubated in ADSC basal medium supplemented with 2% fetal bovine serum and recombinant human TGFβ1 (10 ng/mL; PeproTech) or 10% serum from patients with early dcSSc (n = 6) and healthy individuals (n = 6) for 72 and 96 h for subsequent analyses of mRNA and protein expression levels of relevant markers, respectively. Each serum sample was tested individually. The medium was changed, and additives replenished, every day.
+ Open protocol
+ Expand
2

Expansion of Adipose-Derived and Articular Chondrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADSCs (PT-5006, Lonza) (<6th passage) were cultured in 175 cm2 flasks in ADSC Basal Medium (ADSC-BM) (PT-3273, Lonza) supplemented with ADSC Growth Medium (ADSC-GM) SingleQuots (PT-4503, Lonza). Cultures were maintained in a humidified incubator at 37°C and 5% CO2.
AC cells (CC-2550, Lonza) were cultured at the recommended seeding density (10,000 cells/cm2) from passage 2 to passage 6 in 25, 75 and 175 cm2 culture flasks. The expansion medium was composed of Chondrocyte Basal Medium (CBM) (CC-3217, Lonza) plus SingleQuots of Growth Supplements (CC-4409, Lonza) containing R3-IGF-1, bFGF, transferrin, insulin, FBS and gentamicin/amphotericin-B. Cultures were maintained in a humidified incubator at 37°C and 5% CO2.
+ Open protocol
+ Expand
3

CRISPR-mediated BRCA1 knockdown in ASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
One commercial ASC line (Lonza PT-5006) was obtained for CRISPR-mediated BRCA1 knockdown. ASCs were maintained in ASC growth media (Lonza PT-3273 & PT-4503). Cell media was changed every 3 days, and 0.5% Typsin were used to passage the cells every 6 days according to published protocol (9 (link)). Maintenance of adipogenesis of the ASCs was confirmed by culturing 1×105 ASCs in adipogenic induction media (Lonza PT-3004) for 14 days. Cells were fixed with 4% paraformaldehyde and stained with Oil Red O (Sigma O0625).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!